| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.19 | 0.2 |